Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Buyback Execution

19 Nov 2021 16:51

RNS Number : 0276T
Banco Bilbao Vizcaya Argentaria SA
19 November 2021
 

Banco Bilbao Vizcaya Argentaria, S.A. ("BBVA" or the "Company"), in compliance with the Spanish Securities Market legislation, hereby proceeds to notify the following:

 

INSIDE INFORMATION

 

Further to the notice of Inside Information of 29 October 2021, with registration number 1127 (the "Initial II")[1], BBVA hereby gives notice of the execution of the First Tranche, which will be carried out within the scope of the Program Scheme of up to 3,500 million euros[2], and in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse and Commission Delegated Regulation (EU) No. 2016/1052, of 8 March 2016, (the "Regulations"), under the terms and conditions detailed below:

Purpose:

To reduce BBVA's share capital by means of the redemption of the shares acquired in executing the First Tranche.

Maximum cash amount:

The maximum cash amount of the First Tranche will be 1,500 million euros.

Maximum number of shares:

The maximum number of BBVA shares to be acquired in executing the First Tranche will not exceed 637,770,016, representing, approximately, 9.6% of BBVA's share capital as of the date of this notice.

Start of the First Tranche:

The First Tranche will start on 22 November 2021.

End of the First Tranche:

The First Tranche will end neither before 16 February 2022 nor later than 5 April 2022 and, in any event, when within such period the maximum cash amount is reached or the maximum number of shares is acquired.

However, the Company reserves the right to temporarily suspend the First Tranche or to early terminate it in the event of any circumstance that so advises or requires.

Trading venues:

The acquisitions under the First Tranche will be made on the Spanish Electronic Trading Interconnection System - Continuous Market, as well as on DXE Europe, Turquoise Europe and Aquis Exchange.

Manager:

The First Tranche will be executed externally through J.P. Morgan AG, who will make its decisions concerning the timing of the purchases of the BBVA shares independently of the Company.

Other conditions:

The own shares will be purchased observing in all cases the conditions and the limits established in the Regulations. In particular, shares purchased on any trading day may not exceed 25% of the average daily volume of the shares on the trading venue on which the purchase is made, and the average daily volume of each trading venue will be that corresponding to the twenty trading days prior to the date of each purchase.

The share purchases made, as well as the interruption or termination of the First Tranche, will be duly reported to the Spanish National Securities Market Commission and the appropriate authorities in accordance with the Regulations.

 

Madrid, 19 November 2021

 

[1] The terms First Tranche and Program Scheme will have the same meaning as established in the Initial II.

 

[2] In accordance with the authorization granted by the European Central Bank, the Program Scheme has a maximum amount of 3,500 million euros, and shares may be repurchased up to 10% of BBVA's share capital, during a maximum term of one year from the publication of the Initial II.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZMMMVLNGMZM
Date   Source Headline
31st Oct 20197:00 amRNS3Q19 Results Press Release
21st Oct 20195:05 pmRNS3Q19 Results Presentation Announcement
8th Oct 20197:41 amRNSCorporate Transactions
3rd Oct 20197:00 amRNSDividend October 2019
30th Sep 20197:00 amRNSRelevant Information DCN
24th Sep 20198:15 amRNSPre-Stabilisation Notice - BBVA
29th Aug 20197:00 amRNSOffer of securities contingently convertible
28th Aug 20197:00 amRNSPreferred securities contingently convertible
8th Aug 20197:00 amRNSSale of BBVA Paraguay
5th Aug 201912:07 pmRNSPost-Stabilisation Notice - BBVA
31st Jul 20198:18 amRNS2Q19 Results Report
31st Jul 20198:14 amRNS2Q19 Results Presentation
31st Jul 20197:08 amRNS2Q19 Results Press Release
18th Jul 20195:32 pmRNS2Q19 Results Presentation Announcement
4th Jul 20195:19 pmRNSFitch Ratings upgrade
21st Jun 20195:25 pmRNSTransfer of credits rights
12th Jun 20198:03 amRNSPre-Stabilisation Notice - BBVA
29th Apr 20195:24 pmRNSAppointments at the board of Directors
29th Apr 20195:20 pmRNS1Q19 Results Presentation
29th Apr 20195:08 pmRNS1Q19 Results Press Release
29th Apr 20195:06 pmRNS1Q19 Results Report
26th Apr 201910:41 amRNS2018 Audited Financial Statements
25th Apr 201910:48 amRNSPost Stabilisation Notice
17th Apr 201910:48 amRNS1Q19 Results Presentation Announcement
12th Apr 20197:00 amRNSGlobal Medium Term Programme - Venue change
20th Mar 201910:52 amRNSPost Stabilisation Notice - BBVA
20th Mar 20197:00 amRNSIssue of securities convertible into BBVA shares
19th Mar 201910:42 amRNSPre Stabilisation Notice
18th Mar 20193:42 pmRNSPrudential Relevance Report Pillar III in 2018
18th Mar 20193:36 pmRNSResolutions adopted by the AGM
20th Feb 20197:00 amRNSRedemption of Subordinated Notes
15th Feb 20197:00 amRNSCapital Requirements for 2019
13th Feb 20198:02 amRNS2019 AGM Proposed Resolutions
12th Feb 20197:00 amRNSFinal dividend calendar 2018
11th Feb 20196:07 pmRNS2019 Annual General Meeting Call
1st Feb 20197:00 amRNSFinal dividend for 2018
1st Feb 20197:00 amRNS4Q18 Results Report
1st Feb 20197:00 amRNS4Q18 Results Press Release
1st Feb 20197:00 amRNS4Q18 Results Presentation
28th Jan 20195:38 pmRNS4Q18 Results Presentation Announcement
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
27th Dec 20187:00 amRNSAgreement with Voyager Investing UK Limited
24th Dec 20187:00 amRNSBBVA gives full effect to its succession plan
21st Dec 20187:00 amRNSSuccession plans for Executive Chairman and CEO
20th Dec 20187:00 amRNSEstrategy automobile financing business in Chile
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.